NeuroAIDS: A watershed for mental health and nervous system disorders

Journal of Psychiatry and Neuroscience

Volumn 34, Issue 2, 2009, Pages 83-85

  McCombe, Jennifer A ^a   Noorbakhsh, Farshid ^a   Buchholz, Craig ^a   Trew, Michael ^b   Power, Christopher ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; EFAVIRENZ; LOPINAVIR PLUS RITONAVIR; PEGINTERFERON ALPHA; STAVUDINE; VALPROIC ACID;

AIDS RELATED COMPLEX; BIPOLAR DISORDER; BRAIN PROTECTION; CD4 LYMPHOCYTE COUNT; CENTRAL NERVOUS SYSTEM DISEASE; COMORBIDITY; DEMENTIA; DIABETES MELLITUS; DISEASE ASSOCIATION; DRUG CROSS REACTIVITY; EDITORIAL; HEALTH CARE COST; HEPATITIS C; HIGH RISK BEHAVIOR; HIGH RISK PATIENT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; HYPERTENSION; IMMUNOSURVEILLANCE; INFECTION RISK; INTRAVENOUS DRUG ABUSE; LYMPHOCYTIC INFILTRATION; MENTAL DISEASE; MORTALITY; NEUROAIDS; QUALITY OF LIFE; RISK ASSESSMENT; RISK FACTOR; SENSORY NEUROPATHY; SURVIVAL RATE; UNSAFE SEX; VIRUS TRANSMISSION; VIRUS VIRULENCE; ACQUIRED IMMUNE DEFICIENCY SYNDROME; BEHAVIOR; DISEASE TRANSMISSION; NEUROLOGIC DISEASE; RISK;

AIDS DEMENTIA COMPLEX; BEHAVIOR; HIV INFECTIONS; HUMANS; MENTAL DISORDERS; NERVOUS SYSTEM DISEASES; RISK;

EID: 65649114414     PISSN: 11804882     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (30)

1. Prince M, Patel V, Saxena S, et al. No health without mental health. Lancet 2007;370:859-77.
2. Patrick MK, Johnston JB, Power C. Lentiviral neuropathogenesis: comparative neuroinvasion, neurotropism, neurovirulence, and host neurosusceptibility. J Virol 2002;76:7923-31.
3. Pandya R, Krentz HB, Gill MJ, et al. HIV-related neurological syndromes reduce health-related quality of life. Can J Neurol Sci 2005;32:201-4.
4. Yeung H, Krentz HB, Gill MJ, et al. Neuropsychiatric disorders in HIV infection: impact of diagnosis on economic costs of care. AIDS 2006;20:2005-9.
5. McArthur JC, Brew BJ, Nath A. Neurological complications of HIV infection. Lancet Neurol 2005;4:543-55.
6. Van Rie A, Harrington PR, Dow A, et al. Neurologic and neuro-developmental manifestations of pediatric HIV/AIDS: a global perspective. Eur J Paediatr Neurol 2007;11:1-9.
7. Sacktor N. The epidemiology of human immunodeficiency virus-associated neurological disease in the era of highly active antiretroviral therapy. J Neurovirol 2002;8(Suppl 2):115-21.
8. Ickovics JR, Hamburger ME, Vlahov D, et al. Mortality, CD4 cell count decline, and depressive symptoms among HIV-seropositive women: longitudinal analysis from the HIV Epidemiology Research Study. JAMA 2001;285:1466-74.
9. Leserman J, Petitto JM, Gu H, et al. Progression to AIDS, a clinical AIDS condition and mortality: psychosocial and physiological predictors. Psychol Med 2002;32:1059-73.
10. Chin-Hong PV, Deeks SG, Liegler T, et al. High-risk sexual behavior in adults with genotypically proven antiretroviral-resistant HIV infection. J Acquir Immune Defic Syndr 2005;40:463-71.
11. Brew BJ. Evidence for a change in AIDS dementia complex in the era of highly active antiretroviral therapy and the possibility of new forms of AIDS dementia complex. AIDS 2004;18(Suppl 1):S75-8.
12. Bica I, McGovern B, Dhar R, et al. Increasing mortality due to endstage liver disease in patients with human immunodeficiency virus infection. Clin Infect Dis 2001;32:492-7.
13. Weiss JJ, Gorman JM. Psychiatric behavioral aspects of comanagement of hepatitis C virus and HIV. Curr HIV/AIDS Rep 2006;3:176-81.
14. Douaihy A, Hilsabeck RC, Azzam P, et al. Neuropsychiatric aspects of coinfection with HIV and hepatitis C virus. AIDS Read 2008;18:425-432, 438-429.
15. Gritz ER, Vidrine DJ, Lazev AB, et al. Smoking behavior in a low-income multiethnic HIV/AIDS population. Nicotine Tob Res 2004;6:71-7.
16. Crothers K, Griffith TA, McGinnis KA, et al. The impact of cigarette smoking on mortality, quality of life, and comorbid illness among HIV-positive veterans. J Gen Intern Med 2005;20:1142-5.
17. Keswani SC, Pardo CA, Cherry CL, et al. HIV-associated sensory neuropathies. AIDS 2002;16:2105-17.
18. Jones G, Power C. Regulation of neural cell survival by HIV-1 infection. Neurobiol Dis 2006;21:1-17.
19. Dube B, Benton T, Cruess DG, et al. Neuropsychiatric manifestations of HIV infection and AIDS. J Psychiatry Neurosci 2005;30:237-46.
20. Repetto MJ, Petitto JM. Psychopharmacology in HIV-infected patients. Psychosom Med 2008;70:585-92.
21. World Health Organization. "3 by 5" Progress Report, December 2004. Geneva: World Health Organization and Joint United Nations Programme on HIV/AIDS; 2004. Available: www.who.int/3by5/ progressreport05/en/ (accessed 2009 Feb. 3).
22. Harter M, Baumeister H, Reuter K, et al. Increased 12-month prevalence rates of mental disorders in patients with chronic somatic diseases. Psychother Psychosom 2007;76:354-60.
23. Dougherty RH, Skolasky RL Jr, McArthur JC. Progression of HIV-associated dementia treated with HAART. AIDS Read 2002;12:69-74.
24. Evers S, Rahmann A, Schwaag S, et al. Prevention of AIDS dementia by HAART does not depend on cerebrospinal fluid drug penetrance. AIDS Res Hum Retroviruses 2004;20:483-91.
25. McCombe JA, Auer RN, Maingat FG, et al. Neurological immune reconstitution inflammatory syndrome in HIV/AIDS: outcomes and epidemiology. Neurology. In press.
26. Venkataramana A, Pardo CA, McArthur JC, et al. Immune reconstitution inflammatory syndrome in the CNS of HIV-infected patients. Neurology 2006;67:383-8.
27. Rihs TA, Begley K, Smith DE, et al. Efavirenz and chronic neuropsychiatric symptoms: a cross-sectional case control study. HIV Med 2006;7:544-8.
28. ter Hofstede HJ, Burger DM, Koopmans PP. Antiretroviral therapy in HIV patients: aspects of metabolic complications and mitochondrial toxicity. Neth J Med 2003;61:393-403.
29. Sheehan NL, Brouillette MJ, Delisle MS, et al. Possible interaction between lopinavir/ritonavir and valproic Acid exacerbates bipolar disorder. Ann Pharmacother 2006;40:147-50.
30. Noorbakhsh F, Overall CM, Power C. Deciphering complex mechanisms in neurodegenerative diseases: the advent of systems biology. Trends Neurosci 2009 Jan. 8 [Epub ahead of print].